Key Decisions and Financial Results
1. Unaudited Financial Results for Q1 FY27
The Board approved the unaudited financial results for the quarter ended June 30, 2026:
Consolidated Results (₹ in millions):
- Revenue from operations: ₹6,972.00 (Q1 FY26: ₹5,437.16)
- Other income: ₹31.87 (Q1 FY26: ₹12.00)
- Total income: ₹7,003.87 (Q1 FY26: ₹5,449.16)
- Profit before tax: ₹476.72 (Q1 FY26: ₹460.99)
- Profit after tax: ₹350.95 (Q1 FY26: ₹335.96)
- Basic EPS: ₹6.34 (Q1 FY26: ₹6.07)
- Diluted EPS: ₹6.33 (Q1 FY26: ₹6.06)
Standalone Results (₹ in millions):
- Revenue from operations: ₹4,822.75 (Q1 FY26: ₹3,657.58)
- Other income: ₹21.88 (Q1 FY26: ₹17.42)
- Total income: ₹4,844.63 (Q1 FY26: ₹3,675.00)
- Profit before tax: ₹464.21 (Q1 FY26: ₹354.44)
- Profit after tax: ₹342.66 (Q1 FY26: ₹262.33)
- Basic EPS: ₹6.19 (Q1 FY26: ₹5.85)
The results were reviewed by the Audit Committee and subjected to limited review by statutory auditors Walker Chandiok & Co LLP.
2. ESOP Grant under Rossari Employee Stock Option Plan - 2019
The Board approved grant of 4000 stock options under ESOP 2019:
- Exercise price: ₹531 per option
- Vesting schedule: 20% after 1st year, 20% after 2nd year, 20% after 3rd year, 40% after 4th year
- Exercise period: 5 years from vesting date
- Total potential shares: 4000 equity shares of ₹2 face value each
3. Equity Share Allotment under ESOP 2019
The Board approved allotment of 2500 equity shares of ₹2 each fully paid to grantees upon exercise of options:
- Exercise price per share: ₹425
- Premium per share: ₹423
- Distinctive numbers: 55391617 to 55394116
- Post-allotment paid-up capital: ₹11,07,88,232 consisting of 55,394,116 equity shares
- Shares rank pari passu with existing equity shares
4. Subsidiary Restructuring - Transfer of Rossari International Limited Company
The Board approved transfer of 100% shareholding in Rossari International Limited Company (RILC) to Rossari (Singapore) Pte. Ltd.:
- RILC financial contribution (as of March 31, 2026):
- Turnover: ₹0.22 crores (0.009% of total)
- Net worth: ₹22.425 crores (1.68% of total)
- Consideration: ~₹24 crores for 9,000 shares of face value SAR 1,000 each
- Expected completion: By March 31, 2027
- Conditions: Execution of Share Purchase Agreement and approvals from Saudi Arabian authorities
- Transaction classified as related party transaction but conducted at arm's length
- No material impact on consolidated financial position expected
Capital Structure Impact
The equity share allotment increased issued share capital from ₹11,07,77,232 to ₹11,07,88,232 and number of shares from 55,393,866 to 55,394,116.
Auditor Review
The financial results were subjected to limited review by Walker Chandiok & Co LLP, who issued unmodified review reports for both standalone and consolidated results.